Entering text into the input field will update the search result below

FDA OK's Medtronic's Valiant Navion TEVAR device

Oct. 23, 2018 9:20 AM ETMedtronic plc (MDT) StockMDTBy: Douglas W. House, SA News Editor
  • The FDA approves Medtronic's (NYSE:MDT) Valiant Navion thoracic stent graft system for the repair of all lesions of the descending thoracic aorta.
  • The company says the product has a lower profile than the Valiant Captivia device enabling patients with small iliac arteries to be eligible for a TEVAR (thoracic endovascular aneurysm repair) procedure.
  • Shares are down 2% premarket.

Recommended For You

More Trending News

About MDT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDT--
Medtronic plc